USPTO serial 79396488
ATON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 8, 2025
- Examiner
- HUSSAIN, TASNEEM
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ATON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Handelsman
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products, namely, chemical additives, chemical active ingredients, chemical solvents, chemical reagents, chemical preservatives, chemical antioxidants, ethylene oxide, ethylene glycol, chlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology other than for medical use; chemical reagents for developing monoclonal antibodies other than for medical or veterinary use; monoclonal antibodies for diagnostic use, namely, for scientific purposes other than medical; monoclonal antibodies for industrial scientific research use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes intended for the biotechnology industry | ACTIVE | — |
| 005 | Pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; veterinary products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological, biochemical and biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; stem cells for medical use; stem cells for veterinary use; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of micro-organisms for medical use; skin grafts being living tissues; surgical implants made of living tissue; antibodies; diagnostic preparations for medical use; diagnostic preparations for veterinary use; in-vitro diagnostic preparations for medical use; biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; antibiotics | ACTIVE | — |
| 042 | Scientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveying, namely, engineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studies, research and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conducting clinical trials for others; testing of materials; scientific and industrial research, fine tuning industrial processes, namely, troubleshooting of industrial process control computer software problems, data automation using proprietary software to evaluate, analyze and collect service data, professional scientific consultancy, material testing, scientific laboratory services, and computer programming, all these services being dedicated to biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy; industrial and scientific research services in the field of molecular biology and more specifically genomics, proteomics, protein screening and protein interaction research; scientific research and analysis in the field of genetics and genetic engineering and in the field of chemical reagents; research and development of new products for third parties; development and maintenance of computer platforms in the field of the pharmaceutical industry and biotechnology; computer platform as a service [PaaS] featuring software for scientific analysis and research in the field of the pharmaceutical industry and biotechnology; software engineering services for data processing in the field of the pharmaceutical industry and biotechnology; computer programming services for data processing in the field of the pharmaceutical industry and biotechnology; developing and hosting databases in the field of the pharmaceutical industry and biotechnology; scientific data analysis in the field of the pharmaceutical industry and biotechnology; electronic storage of data in the field of the pharmaceutical industry and biotechnology; engineering services for developing computer data banks in the field of the pharmaceutical industry and biotechnology; developing and providing online non-downloadable computer software platforms for scientific analysis and research and antibody data bank, namely, data warehousing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ATON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 14, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 15, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 29, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 29, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 25, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 24, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 9, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 8, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 8, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 29, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 27, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 27, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 27, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 27, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 25, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 2, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 2, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 11, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 1, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 1, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |